- China
- /
- Hospitality
- /
- SZSE:000524
Exploring Harbin Electric And 2 Promising Small Caps In Asia
Reviewed by Simply Wall St
As global markets grapple with economic uncertainty and inflation fears, small-cap stocks in Asia present intriguing opportunities amidst the volatility. In this environment, identifying companies with strong fundamentals and growth potential can be key to uncovering hidden gems like Harbin Electric and other promising small caps in the region.
Top 10 Undiscovered Gems With Strong Fundamentals In Asia
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
Konishi | 0.16% | -0.13% | 13.54% | ★★★★★★ |
ASRock Rack Incorporation | NA | 45.76% | 269.05% | ★★★★★★ |
HeBei Jinniu Chemical IndustryLtd | NA | -4.19% | 11.42% | ★★★★★★ |
Shanghai SK Automation TechnologyLtd | 42.24% | 36.10% | 2.28% | ★★★★★☆ |
Qingmu Tec | 0.53% | 12.87% | -12.65% | ★★★★★☆ |
Shanghai Haixin Group | 0.77% | 1.60% | 8.25% | ★★★★★☆ |
Tait Marketing & Distribution | 0.73% | 7.56% | 15.53% | ★★★★★☆ |
Jiangsu Longda Superalloy | 17.07% | 19.16% | 11.40% | ★★★★★☆ |
Changshu Fengfan Power Equipment | 91.61% | 6.89% | 31.92% | ★★★★☆☆ |
Sichuan Zigong Conveying Machine Group | 31.56% | 11.60% | 4.01% | ★★★★☆☆ |
Underneath we present a selection of stocks filtered out by our screen.
Harbin Electric (SEHK:1133)
Simply Wall St Value Rating: ★★★★★☆
Overview: Harbin Electric Company Limited, along with its subsidiaries, is engaged in the manufacturing and sale of power plant equipment across various regions including China, Asia, Africa, Europe, and the United States, with a market capitalization of approximately HK$9.62 billion.
Operations: The primary revenue stream for Harbin Electric comes from its "New Power System With New Energy As The Main Body" segment, generating CN¥31.38 billion. Other significant contributions include the "Clean and Efficient Industrial Systems" at CN¥4.74 billion and "Other businesses" at CN¥6.72 billion.
Harbin Electric, a smaller player in the electrical industry, has shown impressive financial performance. Its earnings growth of 193% outpaced the industry average of 17%, highlighting its strong market position. With a price-to-earnings ratio of 5.3x, it's valued attractively compared to Hong Kong's market average of 11x. The company reported net income for 2024 at CNY 1.69 billion, up from CNY 575 million the previous year, reflecting significant revenue growth and efficiency improvements. Despite not being free cash flow positive recently, its debt-to-equity ratio decreased from 39% to 35% over five years, indicating prudent financial management.
- Dive into the specifics of Harbin Electric here with our thorough health report.
Review our historical performance report to gain insights into Harbin Electric's's past performance.
Shandong Weigao Orthopaedic Device (SHSE:688161)
Simply Wall St Value Rating: ★★★★★☆
Overview: Shandong Weigao Orthopaedic Device Co., Ltd. specializes in the development, production, and sale of orthopedic medical devices, with a market cap of CN¥11.70 billion.
Operations: Weigao Orthopaedic's primary revenue stream comes from its medical products segment, generating CN¥1.45 billion. The company's financial performance is characterized by a focus on this core segment, which significantly contributes to its overall revenue.
Shandong Weigao Orthopaedic Device is carving a niche in the medical equipment sector, with earnings growth of 97.5% over the past year, outpacing the industry average of -5.7%. The company reported sales of CNY 1.45 billion for 2024, up from CNY 1.28 billion in 2023, and net income rose to CNY 221.81 million from CNY 112.32 million previously. Trading at a discount of about 35% below its estimated fair value, it seems undervalued given its robust financial health and high-quality earnings profile, suggesting potential for future growth as it continues to expand within its market space.
- Navigate through the intricacies of Shandong Weigao Orthopaedic Device with our comprehensive health report here.
Learn about Shandong Weigao Orthopaedic Device's historical performance.
Guangzhou Lingnan Group Holdings (SZSE:000524)
Simply Wall St Value Rating: ★★★★★★
Overview: Guangzhou Lingnan Group Holdings Company Limited operates in the tourism, accommodation, exhibition, scenic spots, and travel sectors in China with a market capitalization of CN¥7.64 billion.
Operations: Lingnan Group's primary revenue streams include tourism, accommodation, exhibitions, scenic spots, and travel services. The company's net profit margin is 3.5%, reflecting its ability to manage costs effectively within these sectors.
Lingnan Group, a promising player in Asia's hospitality sector, has shown impressive financial health with its debt to equity ratio dropping from 13.8% to 1.3% over five years. The company outpaced industry peers with earnings growth of 118.1%, while net income surged to CNY 150 million from CNY 69 million the previous year. Despite its modest size, Lingnan's robust cash position and positive free cash flow underscore its operational efficiency. With a proposed dividend of CNY 0.80 per share and high-quality past earnings, it seems well-positioned for continued growth in the coming years within the competitive landscape.
Key Takeaways
- Delve into our full catalog of 2621 Asian Undiscovered Gems With Strong Fundamentals here.
- Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
- Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Searching for a Fresh Perspective?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
If you're looking to trade Guangzhou Lingnan Group Holdings, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.
With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.
Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.
Sponsored ContentNew: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SZSE:000524
Guangzhou Lingnan Group Holdings
Engages in the tourism, accommodation, exhibition, scenic spots, and travel businesses in China.
Flawless balance sheet with high growth potential.
Market Insights
Community Narratives

